To investigate the impact of METTL3 on NPC, we downregulated METTL3 expression in NPC cells using shRNA and validated it through Western blot (WB) and quantitative PCR (qPCR) assays (Figure S1A-B). The gene discussed is METTL3; the disease is nasopharyngeal carcinoma.